ID

18208

Descrizione

A Study of Lenalidomide Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Patients With Multiple Myeloma; ODM derived from: https://clinicaltrials.gov/show/NCT00424047

collegamento

https://clinicaltrials.gov/show/NCT00424047

Keywords

versioni (1)
  1. 25/10/16 25/10/16 -
Caricato su

25 ottobre 2016

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Multiple Myeloma NCT00424047

Inglese

Eligibility Multiple Myeloma NCT00424047

1 moduli  
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
prior or current diagnosis durie-salmon stage ii or iii multiple myeloma.
Descrizione

Multiple Myeloma | Staging

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0026764
UMLS CUI [2]
C0332305
measurable levels of myeloma paraprotein in serum or urine (24-hour collection sample).
Descrizione

Serum paraprotein measurement Multiple Myeloma | Urine paraprotein measurement Multiple Myeloma | Specimen Collection 24 Hours

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0585639
UMLS CUI [1,2]
C0026764
UMLS CUI [2,1]
C0585640
UMLS CUI [2,2]
C0026764
UMLS CUI [3,1]
C0200345
UMLS CUI [3,2]
C1442770
eastern cooperative oncology group (ecog) performance status score of 0,1, or 2
Descrizione

ECOG performance status

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1520224
females of childbearing potential must have a negative serum or urine pregnancy test within 7 days of starting study drug
Descrizione

Childbearing Potential Serum pregnancy test negative | Childbearing Potential Urine pregnancy test negative

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0430061
UMLS CUI [2,1]
C3831118
UMLS CUI [2,2]
C0430057
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
prior development of disease progression during high-dose dexamethasone containing therapy
Descrizione

Dexamethasone High dose | Disease Progression

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0011777
UMLS CUI [1,2]
C0444956
UMLS CUI [2]
C0242656
pregnant or lactating females
Descrizione

Pregnancy | Breast Feeding

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
the development of a desquamating rash while taking thalidomide
Descrizione

Thalidomide | Rash desquamating

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0039736
UMLS CUI [2]
C0542171
use of any standard/experimental anti-myeloma therapy within 28 days of randomization or use of any experimental non-drug therapy within 56 days of initiation of drug treatment
Descrizione

Therapeutic procedure Against Multiple Myeloma | Investigational Therapies Against Multiple Myeloma | Therapies, Investigational

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0521124
UMLS CUI [1,3]
C0026764
UMLS CUI [2,1]
C0949266
UMLS CUI [2,2]
C0521124
UMLS CUI [2,3]
C0026764
UMLS CUI [3]
C0949266
laboratory abnormalities: absolute neutrophil count less than 1,000 cells/mm^3
Descrizione

LABORATORY ABNORMALITIES | Absolute neutrophil count

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1853129
UMLS CUI [2]
C0948762
laboratory abnormalities: platelet count < 75,000/mm^3
Descrizione

LABORATORY ABNORMALITIES | Platelet Count measurement

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1853129
UMLS CUI [2]
C0032181
laboratory abnormalities: serum creatinine > 2.5 mg/dl
Descrizione

LABORATORY ABNORMALITIES | Creatinine measurement, serum

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1853129
UMLS CUI [2]
C0201976
laboratory abnormalities: serum glutamic oxaloacetic transaminase (sgot)/aspartate aminotransferase (ast) or serum glutamic pyruvic transaminase (sgpt)/alanine aminotransferase (alt) > 3.0 x upper limit of normal
Descrizione

LABORATORY ABNORMALITIES | Aspartate aminotransferase measurement | Alanine aminotransferase measurement

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1853129
UMLS CUI [2]
C0201899
UMLS CUI [3]
C0201836
laboratory abnormalities: serum total bilirubin > 2.0 mg/dl
Descrizione

LABORATORY ABNORMALITIES | Serum total bilirubin measurement

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1853129
UMLS CUI [2]
C1278039
prior history of malignancies other than multiple myeloma unless the subject has been free of the disease for ≥ 3 years.
Descrizione

Malignant Neoplasms | Multiple Myeloma

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2]
C0026764
Ritorna all'inizio della pagina

Similar models

Eligibility Multiple Myeloma NCT00424047

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
Multiple Myeloma | Staging
Item
prior or current diagnosis durie-salmon stage ii or iii multiple myeloma.
boolean
C0026764 (UMLS CUI [1])
C0332305 (UMLS CUI [2])
Serum paraprotein measurement Multiple Myeloma | Urine paraprotein measurement Multiple Myeloma | Specimen Collection 24 Hours
Item
measurable levels of myeloma paraprotein in serum or urine (24-hour collection sample).
boolean
C0585639 (UMLS CUI [1,1])
C0026764 (UMLS CUI [1,2])
C0585640 (UMLS CUI [2,1])
C0026764 (UMLS CUI [2,2])
C0200345 (UMLS CUI [3,1])
C1442770 (UMLS CUI [3,2])
ECOG performance status
Item
eastern cooperative oncology group (ecog) performance status score of 0,1, or 2
boolean
C1520224 (UMLS CUI [1])
Childbearing Potential Serum pregnancy test negative | Childbearing Potential Urine pregnancy test negative
Item
females of childbearing potential must have a negative serum or urine pregnancy test within 7 days of starting study drug
boolean
C3831118 (UMLS CUI [1,1])
C0430061 (UMLS CUI [1,2])
C3831118 (UMLS CUI [2,1])
C0430057 (UMLS CUI [2,2])
Item Group
C0680251 (UMLS CUI)
Dexamethasone High dose | Disease Progression
Item
prior development of disease progression during high-dose dexamethasone containing therapy
boolean
C0011777 (UMLS CUI [1,1])
C0444956 (UMLS CUI [1,2])
C0242656 (UMLS CUI [2])
Pregnancy | Breast Feeding
Item
pregnant or lactating females
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Thalidomide | Rash desquamating
Item
the development of a desquamating rash while taking thalidomide
boolean
C0039736 (UMLS CUI [1])
C0542171 (UMLS CUI [2])
Therapeutic procedure Against Multiple Myeloma | Investigational Therapies Against Multiple Myeloma | Therapies, Investigational
Item
use of any standard/experimental anti-myeloma therapy within 28 days of randomization or use of any experimental non-drug therapy within 56 days of initiation of drug treatment
boolean
C0087111 (UMLS CUI [1,1])
C0521124 (UMLS CUI [1,2])
C0026764 (UMLS CUI [1,3])
C0949266 (UMLS CUI [2,1])
C0521124 (UMLS CUI [2,2])
C0026764 (UMLS CUI [2,3])
C0949266 (UMLS CUI [3])
LABORATORY ABNORMALITIES | Absolute neutrophil count
Item
laboratory abnormalities: absolute neutrophil count less than 1,000 cells/mm^3
boolean
C1853129 (UMLS CUI [1])
C0948762 (UMLS CUI [2])
LABORATORY ABNORMALITIES | Platelet Count measurement
Item
laboratory abnormalities: platelet count < 75,000/mm^3
boolean
C1853129 (UMLS CUI [1])
C0032181 (UMLS CUI [2])
LABORATORY ABNORMALITIES | Creatinine measurement, serum
Item
laboratory abnormalities: serum creatinine > 2.5 mg/dl
boolean
C1853129 (UMLS CUI [1])
C0201976 (UMLS CUI [2])
LABORATORY ABNORMALITIES | Aspartate aminotransferase measurement | Alanine aminotransferase measurement
Item
laboratory abnormalities: serum glutamic oxaloacetic transaminase (sgot)/aspartate aminotransferase (ast) or serum glutamic pyruvic transaminase (sgpt)/alanine aminotransferase (alt) > 3.0 x upper limit of normal
boolean
C1853129 (UMLS CUI [1])
C0201899 (UMLS CUI [2])
C0201836 (UMLS CUI [3])
LABORATORY ABNORMALITIES | Serum total bilirubin measurement
Item
laboratory abnormalities: serum total bilirubin > 2.0 mg/dl
boolean
C1853129 (UMLS CUI [1])
C1278039 (UMLS CUI [2])
Malignant Neoplasms | Multiple Myeloma
Item
prior history of malignancies other than multiple myeloma unless the subject has been free of the disease for ≥ 3 years.
boolean
C0006826 (UMLS CUI [1])
C0026764 (UMLS CUI [2])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial